University of Birmingham and NHS Foundation Trusts in the UK has selected a 50:50 joint venture between Bruntwood and Legal & General as the preferred bidder to develop Birmingham Life Sciences Park (BLSP) in Selly Oak. 

The development will provide up to 657,000 sq ft state-of-the-art lab, office, and incubation space providing co-location opportunities for all stages of health and life science businesses. The first phase includes a 133,000 sq ft, six-story building housing a new innovation center – the Precision Health Technologies Accelerator (PHTA) - that will bring together the leading strengths of the region in genomics and diagnostics for healthcare technologies development and evaluation, clinical trials, and healthcare data and informatics. The PHTA will provide a range of prototyping, incubation, and laboratory facilities for early-stage businesses and access to business support to develop and rapidly bring innovations to the market.

MedTech, precision medicine, diagnostics, and digital healthcare; creating a thriving cluster of businesses working together and in collaboration with the surrounding clinical and academic community.

The 10-acre site has already received development funding from Birmingham City Council and the Greater Birmingham and Solihull Local Enterprise Partnership and has been designated a Life Science Opportunity Zone by the Department for Business, Energy, and Industrial Strategy (BEIS). It will catalyze the development of a new high-growth life sciences cluster for the city and region and by 2030 Birmingham Health Innovation Campus will have seen GBP 210 million (US$ 273.92 million) investment, creating around 10,000 new jobs, and delivering more than GBP 400 million (US$ 521.75 million) to the local economy.